T1DM patients show a significant increase in peripheral blood CD8+γδ T cells after 3–6 months of insulin treatment (56), suggesting the expansion of a potential regulatory subset induced by exogenous insulin. This evidence concerns the gene CD8A and type 1 diabetes mellitus.